SXKT Medical Technology Group is a high-tech enterprise focusing on the research and development, production and sales of three types of implanted medical device products. The main products are used in neurosurgery skull repair and cardiothoracic surgery and sternum fixation.
SXKT takes neurosurgery implantable consumables as its core product, forming two major product systems, skull repair and skull fixation, and achieves industry leadership in market segments. The main products include titanium skull repair and fixation products for neurosurgery implantation and PEEK skull repair and fixation products, as well as other products such as sternum fixation products, neurospine products, and supporting implant tools.
Products
Neurosurgery Products
Internal fixation titanium mesh system
Polyetheretherketone skull repair system
PEEK Cranial Fixation System
Bippler Bioplate Internal Fixation System
Thoracic surgery products
PEEK sternum fixation band
Sternal fixation system
Rib Plate System
III. Neurospine Products
Anterior Cervical Fixation System
Cervical interbody fusion cage
Spine minimally invasive fixation system
Posterior cervical fixation system
Lumbar internal fixation system
Lumbar interbody fusion cage
Oral Implant System
Titanium and titanium alloy artificial dental implants
V. Other surgical products
Surgical hernia repair patch
Lamina plate
…
The main products involve multiple innovations and multiple technologies to achieve localized substitution
The market performance of SXKT's main products is good. In terms of PEEK cranial bone repair and fixation products, China has obtained the registration certificate of PEEK cranial bone repair products. There are 4 manufacturers, including international giant Johnson & Johnson Syndicate and Chinese local manufacturers MP Medical, KE Medical and SXKT Medical. Among them, the KE medical PEEK bone plate registration certificate was obtained in December 2019, and sales have not yet formed in 2019. SXKT Medical is the first company in China to have a registration certificate for domestic PEEK skull repair products. In 2018, SXKT occupied approximately 75% of the market share of PEEK skull repair products, realizing a domestic replacement. The sales revenue of the company's PEEK skull repair products in 2018 and 2019 increased by 115.77% and 61.61%, respectively, and the sales revenue of the company's PEEK skull fixation products in 2018 and 2019 increased by 89.15% and 115.74%, respectively.
In addition, SXKT also has the only PEEK link sheet registration certificate in China, which is original and has formed a complete PEEK skull repair and fixation product line. From 2017 to 2019, SXKTPEEK repair products continued to occupy the largest market share, with market shares of 73%, 75%, and 71% respectively. SXKT's PEEK cranial fixation film is the first in China. Up to now, SXKT is the only company in China that has a registration certificate for the PEEK material cranial linkage film, with a market share of 100%.
Ranked first among domestic brands, market share is among the top
In terms of titanium material products, the sales revenue of the company's titanium skull repair products in 2018 and 2019 increased by 18.26% and 12.77% respectively. The sales revenue of titanium skull fixation products in 2018 and 2019 increased by 28.12% and 13.31% respectively. From 2017 to 2019, the market share of SXKT titanium skull repair products was 5.2%, 6.3%, and 7.3%, and the market share of titanium skull fixation products were 9.5%, 11.2%, and 11.7%. The market share was steadily increasing. In 2018 SXKT ranks third in the market share of titanium skull repair and fixation products, and ranks first among domestic brands. The market sales of SXKT's various products have maintained a steady growth trend in recent years.
Market space will usher in heavy volume, listing will enhance competitiveness
In 2023, China's cranial and jaw repair and fixation products market will reach 1.75 billion yuan, with a compound growth rate of 15.3% from 2018 to 2023. In the future, as the incidence of related diseases increases, and the mortality rate of related trauma and craniectomy decompression surgery decreases, the treatment rate of subsequent skull repairs increases, and the demand for cranial jaw repair products is expected to increase. On the other hand, with higher prices and better performance than traditional titanium materials, the penetration rate of PEEK cranioplasty and fixation products gradually increases, which will also drive the increase in the market scale of China's cranial and jaw fixation products. At present, SXKT has obtained 12 registration certificates of Class III implantable medical devices, involving the first products in multiple subdivisions. It is one of the few companies in China that can provide diversified neurosurgical skull repair and fixation solutions based on the needs of patients.
SXKT said that the company will also take this listing as an opportunity to continue to maintain the company's leading position in the neurosurgery segment in China through the construction of raised funds for investment projects, further increase market share, and further expand overseas markets; On the one hand, we continue to enrich the product series in the fields of cardiothoracic surgery and stomatology, improve the product layout, and continuously improve the company's comprehensive competitiveness.